Cullinan Therapeutics, Inc. (CGEM)
NASDAQ: CGEM · Real-Time Price · USD
12.23
+0.38 (3.21%)
At close: Feb 6, 2026, 4:00 PM EST
12.47
+0.24 (1.96%)
After-hours: Feb 6, 2026, 7:07 PM EST
Cullinan Therapeutics Market Cap
Cullinan Therapeutics has a market cap or net worth of $722.5 million as of February 6, 2026. Its market cap has increased by 17.50% in one year.
Market Cap
722.50M
Enterprise Value
391.09M
1-Year Change
17.50%
Ranking
Category
Stock Price
$12.23
Market Cap Chart
Since the IPO on January 8, 2021, Cullinan Therapeutics's market cap has decreased from $829.45M to $722.50M, a decrease of -12.89%. That is a compound annual growth rate of -2.68%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 6, 2026 | 722.50M | 18.16% |
| Dec 31, 2025 | 611.44M | -13.79% |
| Dec 31, 2024 | 709.21M | 62.69% |
| Dec 29, 2023 | 435.93M | -9.73% |
| Dec 30, 2022 | 482.90M | -28.36% |
| Dec 31, 2021 | 674.05M | -18.74% |
| Jan 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| MiMedx Group | 762.73M |
| KalVista Pharmaceuticals | 753.14M |
| Nektar Therapeutics | 748.77M |
| Bright Minds Biosciences | 744.04M |
| MapLight Therapeutics | 741.03M |
| Arbutus Biopharma | 738.52M |
| Gyre Therapeutics | 716.22M |
| Jade Biosciences | 704.78M |